We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-3.77%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$117B
AUM Growth
-$71.4B
Cap. Flow
-$63.6B
Cap. Flow %
-54.42%
Top 10 Hldgs %
19.61%
Holding
4,580
New
101
Increased
1,974
Reduced
1,229
Closed
1,024

Sector Composition

Rank Sector Weight
1 Technology 22.91%
2 Healthcare 15.27%
3 Financials 13.61%
4 Consumer Discretionary 10.3%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
1076
Bausch Health
BHC
$2.21B
$8.99M 0.01%
393,496
-29,489
-7% -$721K
M icon
1077
Macy's
M
$6.61B
$8.98M 0.01%
368,669
-1,028,166
-74% -$26.3M
LAND
1078
Gladstone Land Corp
LAND
$360M
$8.98M 0.01%
246,505
+6,342
+3% +$205K
LAMR icon
1079
Lamar Advertising Co
LAMR
$16.2B
$8.97M 0.01%
77,246
+2,395
+3% +$267K
AEO icon
1080
American Eagle Outfitters
AEO
$2.97B
$8.96M 0.01%
533,634
+159,278
+43% +$3.37M
PBCT
1081
DELISTED
People's United Financial Inc
PBCT
$8.95M 0.01%
447,963
-370,166
-45% -$7.56M
SNP
1082
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$8.95M 0.01%
180,762
+9,677
+6% +$484K
WCC
1083
WESCO International
WCC
$18.1B
$8.94M 0.01%
68,665
+3,624
+6% +$454K
TDV icon
1084
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$278M
$8.93M 0.01%
143,000
-50,000
-26% -$3.11M
BP icon
1085
BP
BP
$109B
$8.92M 0.01%
303,352
-314,040
-51% -$9.57M
RARE icon
1086
Ultragenyx Pharmaceutical
RARE
$2.54B
$8.89M 0.01%
122,427
+21,983
+22% +$1.53M
THC icon
1087
Tenet Healthcare
THC
$20.7B
$8.89M 0.01%
103,406
-14,187
-12% -$1.17M
DOX icon
1088
Amdocs
DOX
$6.28B
$8.87M 0.01%
107,911
+40,888
+61% +$3.2M
PBF icon
1089
PBF Energy
PBF
$7.26B
$8.83M 0.01%
362,283
-79,322
-18% -$1.5M
RPM icon
1090
RPM International
RPM
$14.8B
$8.75M 0.01%
107,449
-6,491
-6% -$557K
BVN icon
1091
Compañía de Minas Buenaventura
BVN
$8.27B
$8.75M 0.01%
868,702
-22,219
-2% -$206K
NVTA
1092
DELISTED
Invitae Corporation
NVTA
$8.72M 0.01%
1,094,334
+582,299
+114% +$5.86M
HAYW icon
1093
Hayward Holdings
HAYW
$3.32B
$8.7M 0.01%
523,221
+106,854
+26% +$2.02M
GMED icon
1094
Globus Medical
GMED
$11B
$8.69M 0.01%
117,715
-1,345
-1% -$93.5K
CUZ icon
1095
Cousins Properties
CUZ
$4.91B
$8.66M 0.01%
214,927
-7,744
-3% -$305K
LEA icon
1096
Lear
LEA
$7.93B
$8.64M 0.01%
60,617
-6,102
-9% -$992K
OGN icon
1097
Organon & Co
OGN
$3.56B
$8.64M 0.01%
247,428
+14,526
+6% +$497K
ACM icon
1098
Aecom
ACM
$9.63B
$8.61M 0.01%
112,131
-2,040
-2% -$150K
ARKG icon
1099
ARK Genomic Revolution ETF
ARKG
$1.63B
$8.61M 0.01%
187,436
-96,585
-34% -$4.6M
PLNT icon
1100
Planet Fitness
PLNT
$4.05B
$8.57M 0.01%
101,489
+3,729
+4% +$324K

Similar funds

Credit Suisse's Q1 2022 Portfolio in Review

As of Q1 2022, Credit Suisse held 4,580 positions worth $117B, down 38% from $188B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse withdrew a net $63.6B in Q1 2022, closing 1,024 positions and reducing 1,229 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $240M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in AgileThought Inc worth $43.7M.

  • Credit Suisse's largest Q1 2022 buy was AgileThought Inc: 9,605,775 shares worth $43.7M.
  • Credit Suisse added most to S&P Global in Q1 2022, an estimated $190M increase.
  • Credit Suisse's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $306M.
  • Credit Suisse fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $240M.
  • Credit Suisse's ten largest holdings make up 20% of its $117B portfolio in Q1 2022.
  • Credit Suisse opened 101 new positions and closed 1,024 in Q1 2022.
  • Credit Suisse's portfolio value fell 38% quarter-over-quarter to $117B.

Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.